Most people on Ozempic notice some weight loss within the first four weeks, but meaningful results take longer. In clinical trials, participants lost an average of 10.6% of their body weight over the first 20 weeks, with weight continuing to drop for roughly 60 weeks before plateauing. The full timeline depends on how quickly your body tolerates dose increases and how much weight you have to lose.
What Happens in the First Month
Ozempic works by mimicking a gut hormone called GLP-1 that slows digestion and signals fullness to your brain. After your first injection, food physically moves through your stomach more slowly. Studies using imaging to track digestion found that semaglutide increased solid food retention in the stomach by 72% at the two-hour mark and 37% at four hours. That slower emptying, combined with appetite suppression in the brain, means you naturally eat less without white-knuckling through hunger.
During the first four weeks, you’re on the lowest dose (0.25 mg), which is designed to let your body adjust rather than maximize weight loss. Even so, most people lose somewhere in the range of 7 to 10 pounds in that first month. Much of this early loss reflects reduced food intake and water shifts rather than dramatic fat loss, but it’s real progress on the scale.
The Dose Escalation Schedule
Ozempic isn’t a single-dose medication. You start low and increase every four weeks through a series of steps: 0.25 mg, then 0.5 mg, 1 mg, 1.7 mg, and finally 2.4 mg for the weight-loss formulation. The FDA-approved maximum for Ozempic specifically (which is labeled for type 2 diabetes, not weight loss) is 2 mg once weekly. The higher 2.4 mg dose is the same drug marketed as Wegovy for weight management.
This ramp-up matters because your rate of weight loss accelerates as the dose increases. In a trial comparing doses, people on 2.4 mg lost 9.6% of their body weight over 68 weeks, while those on 1.0 mg lost 7.0%. If nausea or other GI side effects hit hard at a particular dose, your prescriber may delay the next increase by four weeks, which stretches the timeline to reach full strength. Some people need 16 to 20 weeks just to get to the maintenance dose, and that’s completely normal.
The 20-Week Checkpoint
Twenty weeks, or roughly five months, is the first major milestone. In the STEP 4 clinical trial, participants had lost an average of 10.6% of their starting body weight by week 20. For someone who started at 220 pounds, that’s about 23 pounds.
This timeframe is also when researchers assess whether the medication is working for you individually. In the trials, “responding” was defined as losing at least 5% of body weight by week 20. About 86% of participants on semaglutide hit that mark by week 68, and being a responder at week 20 was a strong signal: 96.4% of those early responders went on to achieve clinically meaningful weight loss. If you haven’t lost at least 5% by the five-month mark, it doesn’t guarantee the drug won’t work, but the odds are lower.
Peak Results and the Plateau
Weight loss doesn’t continue indefinitely. After the rapid phase in the first five months, the rate slows as your body adapts. People who continued semaglutide in the STEP 4 trial lost an additional 7.9% of body weight between weeks 20 and 68, bringing total loss to about 17.4%. That’s a significant number. For someone starting at 250 pounds, it translates to roughly 43 pounds over about 16 months.
The plateau typically arrives around 60 weeks, or just over a year. At that point, your body has recalibrated its energy balance, your smaller frame burns fewer calories, and the appetite-suppressing effects settle into a steady state. This isn’t the drug “stopping working.” It’s your body reaching a new equilibrium. Some people continue losing small amounts after 60 weeks, but most find their weight stabilizes.
What Happens If You Stop
The STEP 4 trial tested this directly. Participants who switched from semaglutide to a placebo after 20 weeks regained an average of 6.9% of their body weight over the next 48 weeks. That’s most of what they had lost. The appetite suppression and slowed digestion reverse once the drug clears your system, and hunger returns to pre-treatment levels. This is why semaglutide is considered a long-term medication rather than a short course.
Factors That Affect Your Timeline
Starting weight plays a role. People with more weight to lose tend to see larger absolute numbers on the scale, especially early on. Those with type 2 diabetes typically lose less than people without it. In the STEP 2 trial focused on patients with diabetes, the average loss on the highest dose was 9.6% at 68 weeks, compared to higher percentages in trials of people without diabetes.
Side effects can also slow you down. Nausea is the most common complaint, especially during dose increases. If your prescriber needs to hold you at a lower dose for an extra month or two, your weight loss curve shifts to the right. You’ll still get there, but it takes longer. Eating smaller meals, avoiding high-fat foods, and staying hydrated can help you tolerate increases on schedule.
Interestingly, one real-world study found that visits with dietitians or psychology teams were not associated with greater weight loss percentages. That doesn’t mean diet and exercise are irrelevant. The clinical trials required all participants to follow a reduced-calorie diet and increase physical activity, so the baseline already included lifestyle changes. What it suggests is that the medication does the heavy lifting on appetite, and adding more structured counseling on top of that doesn’t appear to move the needle further in measurable ways.
A Realistic Month-by-Month Outlook
- Months 1 to 2: You’re on lower doses. Appetite drops noticeably. Expect 5 to 10 pounds of loss, sometimes more.
- Months 3 to 5: You reach higher doses and weight loss accelerates. Most people have lost around 10% of their starting weight by month five.
- Months 6 to 12: Loss continues but at a slower pace. You’re in the steady grind phase where pounds come off gradually.
- Months 12 to 15: Weight loss tapers and eventually plateaus. Total loss for most people lands between 10% and 17% of starting body weight.
These are averages from clinical trials with thousands of participants. Individual results vary widely. Some people lose 20% or more, others land closer to 5%. The five-month mark is the best early indicator of where you’ll end up.